{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T05:46:47Z","timestamp":1782020807087,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603137"],"award-info":[{"award-number":["81603137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973384"],"award-info":[{"award-number":["81973384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270199"],"award-info":[{"award-number":["82270199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"GuangDong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515012282"],"award-info":[{"award-number":["2023A1515012282"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>High-intensity chemotherapy regimens are often used in adult T-cell lymphoblastic lymphoma (T-LBL) patients. Nevertheless, the response rate remains unsatisfactory due to emergence of chemoresistance. Growing evidence has shown that long non-coding RNAs (lncRNAs) are involved in tumor progression and chemoresistance. Herein, we investigated the potential role of lncRNAs in T-LBLs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>RNAseq was used to screen and identify candidate lncRNAs associated with T-LBL progression and chemoresistance. Luciferase reporter assay was used to examine the binding of miR-371b-5p to the 3\u2019UTR of<jats:italic>Smad2<\/jats:italic>and<jats:italic>LEF1<\/jats:italic>, and the binding of TCF-4\/LEF1 to the promoter of LINC00183. Chromatin immunoprecipitation assay was undertaken to analyze the connection between LEF1 and the LINC00183 promoter region. RNA immunoprecipitation assays were used to explore the mechanism whereby LINC00183 regulated miR-371b-5p. MTT and flow cytometry assays were used to measure apoptosis of T-LBL cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>LINC00183 was upregulated in T-LBL progression and chemoresistant tissues in both the Sun Yat-sen University Cancer Center dataset and the First Affiliated Hospital of Anhui Medical University dataset. High expression of LINC00183 was correlated with poorer overall survival and progression-free survival of T-LBL patients compared to those with low expression of LINC00183. Furthermore, miR-371b-5p was negatively regulated by LINC00183. In vivo and in vitro assays showed that LINC00183-mediated T-LBL chemoresistance depended on miR-371b-5p expression. The direct binding of miR-371b-5p to Smad2 and LEF1 was verified by luciferase assays. It was shown that TCF4\/LEF1 could bind to the LINC00183 promoter site and increase its transcript level. Downregulation of miR-371b-5p led to increased expression of Smad2\/LEF1, and in turn increased LINC00183 expression. Additionally, phospho-Smad2 promotes nuclear translocation of \u03b2-catenin, LINC00183 downregulation decreased chemoresistance induced by \u03b2-catenin and TGF-\u03b21 in T-LBL cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We unraveled a \u03b2-catenin-LINC00183-miR-371b-5p-Smad2\/LEF1 feedback loop that promotes T-LBL progression and chemoresistance, indicating that LINC00183 may serve as a potential therapeutic target in T-LBLs.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13046-023-02670-9","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:02:15Z","timestamp":1682647335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The \u03b2-catenin-LINC00183-miR-371b-5p-Smad2\/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance"],"prefix":"10.1186","volume":"42","author":[{"given":"Wei-Juan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Bin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Qing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Peng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"2670_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.critrevonc.2017.03.020","volume":"113","author":"S Cortelazzo","year":"2017","unstructured":"Cortelazzo S, Ferreri A, Hoelzer D, Ponzoni M. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2017;113:304\u201317.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"2670_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","volume":"144","author":"MJ You","year":"2015","unstructured":"You MJ, Medeiros LJ, Hsi ED. T-lymphoblastic leukemia\/lymphoma. Am J Clin Pathol. 2015;144(3):411\u201322.","journal-title":"Am J Clin Pathol"},{"key":"2670_CR3","doi-asserted-by":"crossref","unstructured":"Bardelli V, Arniani S, Pierini V, Di Giacomo D, Pierini T, Gorello P et al. T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness. Genes (Basel). 2021;12(8).","DOI":"10.3390\/genes12081118"},{"issue":"14","key":"2670_CR4","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1182\/bloodadvances.2020001822","volume":"4","author":"E Kroeze","year":"2020","unstructured":"Kroeze E, Loeffen JLC, Poort VM, Meijerink JPP. T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor? Blood Adv. 2020;4(14):3466\u201373.","journal-title":"Blood Adv"},{"issue":"Suppl 3","key":"2670_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3816\/CLM.2009.s.015","volume":"9","author":"D Hoelzer","year":"2009","unstructured":"Hoelzer D, Gokbuget N. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity? Clin Lymphoma Myeloma. 2009;9(Suppl 3):214\u201321.","journal-title":"Clin Lymphoma Myeloma"},{"issue":"1","key":"2670_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-021-01168-x","volume":"24","author":"T Intermesoli","year":"2022","unstructured":"Intermesoli T, Weber A, Leoncin M, Frison L, Skert C, Bassan R. Lymphoblastic lymphoma: a Concise Review. Curr Oncol Rep. 2022;24(1):1\u201312.","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"2670_CR7","first-page":"416","volume":"95","author":"A Reiter","year":"2000","unstructured":"Reiter A, Schrappe M, Ludwig WD, Tiemann M, Parwaresch R, Zimmermann M, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95(2):416\u201321.","journal-title":"Blood"},{"issue":"14","key":"2670_CR8","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1158\/1078-0432.CCR-19-4207","volume":"26","author":"XP Tian","year":"2020","unstructured":"Tian XP, Su N, Wang L, Huang WJ, Liu YH, Zhang X, et al. A CpG methylation classifier to predict relapse in adults with T-Cell lymphoblastic lymphoma. Clin Cancer Res. 2020;26(14):3760\u201370.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2670_CR9","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1038\/s41375-020-0757-5","volume":"34","author":"XP Tian","year":"2020","unstructured":"Tian XP, Xie D, Huang WJ, Ma SY, Wang L, Liu YH, et al. A gene-expression-based signature predicts survival in adults with T-cell lymphoblastic lymphoma: a multicenter study. Leukemia. 2020;34(9):2392\u2013404.","journal-title":"Leukemia"},{"issue":"10","key":"2670_CR10","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1038\/s41375-019-0466-0","volume":"33","author":"XP Tian","year":"2019","unstructured":"Tian XP, Huang WJ, Huang HQ, Liu YH, Wang L, Zhang X, et al. Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma. Leukemia. 2019;33(10):2454\u201365.","journal-title":"Leukemia"},{"issue":"3","key":"2670_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/ijc.IJC_616_18","volume":"57","author":"M Sengar","year":"2020","unstructured":"Sengar M, Carr R, Jain H, Chanana R, Rangarajan V, Sridhar E, et al. Outcomes of T-lymphoblastic lymphoma treated with pediatric ALL-like protocol. Indian J Cancer. 2020;57(3):262\u20136.","journal-title":"Indian J Cancer"},{"issue":"6","key":"2670_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cac2.12039","volume":"40","author":"XP Tian","year":"2020","unstructured":"Tian XP, Cai J, Ma SY, Fang Y, Huang HQ, Lin TY, et al. BRD2 induces drug resistance through activation of the RasGRP1\/Ras\/ERK signaling pathway in adult T-cell lymphoblastic lymphoma. Cancer Commun (Lond). 2020;40(6):245\u201359.","journal-title":"Cancer Commun (Lond)"},{"issue":"12","key":"2670_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2670_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5\u201318.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2670_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd.2016.117","volume":"16","author":"M Matsui","year":"2017","unstructured":"Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16(3):167\u201379.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"2670_CR16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in Oncology. Cell. 2019;179(5):1033\u201355.","journal-title":"Cell"},{"issue":"1","key":"2670_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","volume":"14","author":"Y Fang","year":"2016","unstructured":"Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in Cancer. Genomics Proteom Bioinf. 2016;14(1):42\u201354.","journal-title":"Genomics Proteom Bioinf"},{"issue":"5","key":"2670_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272\u201383.","journal-title":"Nat Rev Genet"},{"issue":"6","key":"2670_CR19","doi-asserted-by":"publisher","first-page":"194417","DOI":"10.1016\/j.bbagrm.2019.194417","volume":"1863","author":"S Panni","year":"2020","unstructured":"Panni S, Lovering RC, Porras P, Orchard S. Non-coding RNA regulatory networks. Biochim Biophys Acta Gene Regul Mech. 2020;1863(6):194417.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"2670_CR20","doi-asserted-by":"crossref","unstructured":"Lv Y, Wang Y, Zhang Z. Potentials of lncRNA-miRNA-mRNA networks as biomarkers for laryngeal squamous cell carcinoma. Hum Cell. 2022.","DOI":"10.1007\/s13577-022-00799-x"},{"key":"2670_CR21","doi-asserted-by":"crossref","unstructured":"Deng R, Fan FY, Yi H, Liu F, He GC, Sun HP et al. MEG3 affects the progression and chemoresistance of T-cell lymphoblastic lymphoma by suppressing epithelial-mesenchymal transition via the PI3K\/mTOR pathway. J Cell Biochem. 2018.","DOI":"10.1002\/jcb.28093"},{"issue":"21","key":"2670_CR22","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1158\/1078-0432.CCR-14-2947","volume":"21","author":"D Qian","year":"2015","unstructured":"Qian D, Chen K, Deng H, Rao H, Huang H, Liao Y, et al. MicroRNA-374b suppresses proliferation and promotes apoptosis in T-cell lymphoblastic lymphoma by repressing AKT1 and Wnt-16. Clin Cancer Res. 2015;21(21):4881\u201391.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2670_CR23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.cellsig.2016.02.011","volume":"28","author":"DM DiRenzo","year":"2016","unstructured":"DiRenzo DM, Chaudhary MA, Shi X, Franco SR, Zent J, Wang K, et al. A crosstalk between TGF-beta\/Smad3 and Wnt\/beta-catenin pathways promotes vascular smooth muscle cell proliferation. Cell Signal. 2016;28(5):498\u2013505.","journal-title":"Cell Signal"},{"issue":"23","key":"2670_CR24","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1038\/s41388-020-1307-3","volume":"39","author":"WJ Huang","year":"2020","unstructured":"Huang WJ, Tian XP, Bi SX, Zhang SR, He TS, Song LY, et al. The beta-catenin\/TCF-4-LINC01278-miR-1258-Smad2\/3 axis promotes hepatocellular carcinoma metastasis. Oncogene. 2020;39(23):4538\u201350.","journal-title":"Oncogene"},{"issue":"20","key":"2670_CR25","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood"},{"issue":"5","key":"2670_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579\u201386.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2670_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-017-0637-4","volume":"16","author":"XP Tian","year":"2017","unstructured":"Tian XP, Jin XH, Li M, Huang WJ, Xie D, Zhang JX. The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15\/cyclin D1 pathway. Mol Cancer. 2017;16(1):74.","journal-title":"Mol Cancer"},{"issue":"7","key":"2670_CR28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.7150\/thno.30958","volume":"9","author":"XP Tian","year":"2019","unstructured":"Tian XP, Wang CY, Jin XH, Li M, Wang FW, Huang WJ, et al. Acidic Microenvironment Up-Regulates exosomal miR-21 and miR-10b in early-stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis. Theranostics. 2019;9(7):1965\u201379.","journal-title":"Theranostics"},{"issue":"D1","key":"2670_CR29","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127\u2013D31.","journal-title":"Nucleic Acids Res"},{"key":"2670_CR30","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, et al. The biochemical basis of microRNA targeting efficacy. Science. 2019;366:6472.","journal-title":"Science"},{"issue":"1","key":"2670_CR31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1186\/s12859-019-3142-5","volume":"20","author":"D Netanely","year":"2019","unstructured":"Netanely D, Stern N, Laufer I, Shamir R. PROMO: an interactive tool for analyzing clinically-labeled multi-omic cancer datasets. BMC Bioinformatics. 2019;20(1):732.","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"2670_CR32","first-page":"5489","volume":"18","author":"G Zhu","year":"2018","unstructured":"Zhu G, Zhang W, Liu Y, Wang S. miR\u2013371b\u20135p inhibits endothelial cell apoptosis in monocrotaline\u2013induced pulmonary arterial hypertension via PTEN\/PI3K\/Akt signaling pathways. Mol Med Rep. 2018;18(6):5489\u2013501.","journal-title":"Mol Med Rep"},{"issue":"22","key":"2670_CR33","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1038\/s41388-022-02326-6","volume":"41","author":"Y Kim","year":"2022","unstructured":"Kim Y, Ko JY, Lee SB, Oh S, Park JW, Kang HG, et al. Reduced miR-371b-5p expression drives tumor progression via CSDE1\/RAC1 regulation in triple-negative breast cancer. Oncogene. 2022;41(22):3151\u201361.","journal-title":"Oncogene"},{"key":"2670_CR34","doi-asserted-by":"crossref","unstructured":"Tzavlaki K, Moustakas A. TGF-beta Signaling. Biomolecules. 2020;10(3).","DOI":"10.3390\/biom10030487"},{"issue":"6","key":"2670_CR35","first-page":"1389","volume":"7","author":"L Santiago","year":"2017","unstructured":"Santiago L, Daniels G, Wang D, Deng FM, Lee P. Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment. Am J Cancer Res. 2017;7(6):1389\u2013406.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2670_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2021.11.026","volume":"82","author":"HO Iwakawa","year":"2022","unstructured":"Iwakawa HO, Tomari Y. Life of RISC: formation, action, and degradation of RNA-induced silencing complex. Mol Cell. 2022;82(1):30\u201343.","journal-title":"Mol Cell"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02670-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-023-02670-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02670-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T10:19:40Z","timestamp":1729333180000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-023-02670-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2670"],"URL":"https:\/\/doi.org\/10.1186\/s13046-023-02670-9","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"3 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained for all animal studies under the guidelines of Sun Yat-sen University Cancer Center. All clinical study was approved by the Ethics Review Board of Sun Yat-sen University Cancer Center, and written informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interesting.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}